Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics
Acquiring Company
Rhythm Pharmaceuticals
Acquired Company
Laza Medical
BostonCampbellBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologySoftwareHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth DiagnosticsDescription
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that Rhythm’s Netherlands subsidiary, Rhythm Pharmaceuticals Netherlands B.V. (“Rhythm BV”), acquired Xinvento B.V., a Netherlands-based biotech company focused on developing therapies for congenital hyperinsulinism (CHI). CHI is a rare genetic disease in which cells secrete excess insulin, causing hypoglycemia, which can result in serious health outcomes including seizures, coma, permanent brain damage and death.Xinvento was founded in 2021 by Claudine van der Sande, an experienced biopharmaceutical leader who previously held positions at Roche and Sanofi, and whose first-hand experience as a caregiver to her son living with CHI inspired her mission to seek a more effective treatment for CHI patients. Ms. van der Sande partnered with Dr. Piet Wigerinck, a medicinal chemist who served as chief scientific officer of Galapagos for 10 years, to lead the scientific effort. Xinvento is developing novel investigational therapeutic candidates designed to improve the care of patients with CHI.
Quick answer
Rhythm Pharmaceuticals is acquiring Laza Medical and Xinvento B.V, announced February 27, 2023. Rhythm Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did Rhythm Pharmaceuticals pay for Laza Medical?
- The deal value was not disclosed.
- What does Rhythm Pharmaceuticals do?
- Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway..
- Where are Rhythm Pharmaceuticals and Laza Medical based?
- Rhythm Pharmaceuticals is based in Boston, Massachusetts, United States. Laza Medical is based in Campbell, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future (February 27, 2023)
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Bayer Acquires Blackford Analysis Ltd. Bolstering The Company’S Position In Digital Medical Imaging (January 18, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
Who to call at Rhythm Pharmaceuticals, and when
When Rhythm Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Rhythm Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rhythm Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rhythm Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rhythm Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Laza Medical?
Laza Medical was acquired by Rhythm Pharmaceuticals, based in Boston. The deal was reported on February 27, 2023. Rhythm Pharmaceuticals is publicly traded (RYTM) and operates in Biotechnology.
When did Rhythm Pharmaceuticals acquire Laza Medical?
Rhythm Pharmaceuticals's acquisition of Laza Medical was reported on February 27, 2023. Rhythm Pharmaceuticals, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Laza Medical do?
Laza Medical is a privately held portfolio company of Shifamed, LLC., a highly specialized medical innovation hub founded by serial entrepreneur, Amr Salahieh. It is privately held, operating in Biotechnology, and is based in Campbell.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.